However, in our study, the down-expression of E-cadherin alone was confirmed about 73.3% in HCC patients who underwent surgical resection and was not significantly related to vascular invasion, tumor stage, or postoperative prognosis. The gene discussed is CDH1; the disease is hepatocellular carcinoma.